Ann: Top 20 Shareholders Update, page-115

@andrewk65 Indeed that’s the way I look at it too. If there is an international interest at this point in time and people are willing to manipulate the price to a) accumulate b) cap the price c) shake nervous sellers hands then that gives me some confidence that RCE is a stock worth accumulating at this point in time. RSI and MACD indicates a new low as @MoneyMozart pointed out. The only thing that will possibly push the price further south will be a bad announcement. But at this stage I’m hopeful that won't happen with encouraging results from the US University of Tennessee R329 and R529 experiments on SARS-CoV-2. I’d be blindsided if the CSIRO testing came back anything less than encouraging.

Phase I testing at the South Australia’s CMAX Clinical Research Facility is due in Q4 of 2020. This will be massive for RCE. Although I’m confident about the toxicology effect with the data to date on rats, mice and dogs, we still don’t have any scientific date that R327 is non harmful to the human body in the dosages where RCE is affective. We do know that R327 isn’t harmful from a 1ml undiluted (neat) via buccal administration as document in the announcement “Recce Signs Phase I Human Clinical Trial Agreement of Synthetic Antibiotic RECCE® 327 in Healthy Human Subjects”

quoted from the announcement.

‘In anticipation, a respected physician at a leading teaching Australian hospital performed a self dosing treatment that showed No Observed Adverse Effect Levels. The protocol followed saw an escalation of 1ml undiluted (neat) RECCE® 327 via buccal administration. Blood samples were taken, analysed for haematology and clinical biochemistry parameters by a third-party, and results were found to be normal”

Throw the Murdoch Children’s Research Institute - RECCE® 435 Against Helicobacter pylori stomach bacteria in the mix and its only a matter of time before RCE is pushing all time new price highs.

I’m just wondering if the price will slowly creep north or its going to take another good announcement to allow a price run.